Skip to main content

OCS · Oculis Holding AG · Investor Relations

Track OCS — free
$9.34 +0.21 (+2.30%) At close · Sep 30
Market Cap
$514.74M
Shares
55.53M
Volume · Sep 30 434.74K Avg daily vol (3M) 264.19K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-05 00:00 UTC Q3-2026 Earnings Release Earnings call

Past events

Date Event Type
2026-08-26 JPM Aspen Summit Event
2026-08-06 Q2-2026 Earnings Release Earnings call
2026-07-14 Ophthalmology Innovation Source (OIS) Annual Retina Innovation Summit Event
2026-07-10 Piper Sandler Virtual Ophthalmology Conference Conference
2026-06-13 Clinical Trials at the Summit Event
2026-06-10 Goldman Sachs 47th Annual Global Healthcare Conference Conference
2026-06-06 European Neuro-Ophthalmology Society Annual Meeting Shareholder meeting
2026-05-29 DIAMOND Phase 3 Topline Results Conference Call Earnings call
2026-05-17 Retina World Congress Event
2026-05-13 2026 Annual General Meeting of Shareholders Shareholder meeting
2026-05-11 Q1-2026 Earnings Release Earnings call
2026-05-11 2026 AGM – Shareholder Information Session Shareholder meeting
2026-05-07 ARVO Annual Meeting Shareholder meeting
2026-05-05 Swiss Biotech Day Event
2026-05-01 Eyecelerator Event
2026-04-22 AAN Annual Meeting Shareholder meeting
2026-04-16 Van Lanschot Kempen Life Sciences Conference Conference
2026-04-16 Needham Healthcare Conference Conference
2026-03-26 LifeSci Capital Biotech Forum Event
2026-03-25 Leerink Partners Mountain Meeting Event
2026-03-24 NANOS Annual Meeting Shareholder meeting
2026-03-21 COPHy Annual Congress Event
2026-03-11 Leerink Global Healthcare Conference Conference
2026-03-03 Q4/Full Year Earnings Release Earnings call
2026-02-26 Wells Fargo Executive Biotech Summary Event

Source: https://investors.oculis.com/

Key facts CIK 1953530 CUSIP H5870P102 13F (30d) 3 filings 3 filers Visit website Investor relations